Quality of life in patients with primary hyperparathyroidism. (February 2014)

• Record Type: Journal Article
• Authors: Cipriani, Cristiana; Romagnoli, Elisabetta; Cilli, Mirella; Piemonte, Sara; Pepe, Jessica; Minisola, Salvatore
• Is Part Of: Expert review of pharmacoeconomics & outcomes research. Volume 14:Number 1(2014)
• Page Start: 113
• Page End: 121
• Publication Date: 2014-02
• Subjects: Pharmacology -- Economic aspects -- Periodicals; 338.47615105
• DOI: 10.1586/14737167.2014.873702
• Languages: English
• ISSNs: 1473-7167

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>The clinical picture of primary hyperparathyroidism (PHPT) has changed over the last three decades and many asymptomatic patients are now diagnosed through the unexpected finding of high serum calcium levels. However, though not yet considered as typical features of the disease and therefore not included in the guidelines for surgery, many data are available on neuropsycological manifestations and their impact on quality of life in asymptomatic patients. PHPT patients indeed show early experience nonspecific symptoms, such as weakness, depression, sleep disturbance, memory loss and anxiety. Although the underlining mechanisms have not been still identified, the prevalence of psychiatric and cognitive deficits has been investigated in many studies, as well as the possible association with quality of life and well-being improvement after surgery. This article aims to review the current knowledge on quality of life in PHPT patients before and after surgery and the possible clinical implications of these findings.</p> </abstract>